Oct 23 (Reuters) - Indian drugmaker Cipla
signed an agreement with Eli Lilly ( LLY ) to sell tirzepatide,
the active ingredient in the U.S. company's blockbuster
weight-loss drug Mounjaro, in India, the companies said on
Thursday.